<table border="0" cellpadding="0" cellspacing="0" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr>
<td>
<content stylecode="bold">Coadmini</content>
<content stylecode="bold">s</content>
<content stylecode="bold">tered drug</content>
</td>
<td>
<content stylecode="bold">Dose schedules</content>
</td>
<td>
<content stylecode="bold">Effec</content>
<content stylecode="bold">t on other drugs pharmacokinetics</content>
</td>
</tr>
<tr>
<td>
<content stylecode="bold">Coadmini</content>
<content stylecode="bold">s</content>
<content stylecode="bold">tered drug</content>
</td>
<td>
<content stylecode="bold">Quetiapine</content>
</td>
</tr>
<tr>
<td>Lorazepam</td>
<td>2 mg, single dose</td>
<td>250 mg three times daily</td>
<td>Oral clearance of lorazepam reduced by 20%</td>
</tr>
<tr>
<td>Divalproex</td>
<td>500 mg twice daily</td>
<td>150 mg twice daily</td>
<td>C<sub>max </sub>and AUC of free valproic acid at steady-state was decreased by 10 to 12%</td>
</tr>
<tr>
<td>Lithium</td>
<td>Up to 2400 mg/day given in twice daily doses</td>
<td>250 mg three times daily</td>
<td>No effect on steady- state pharmacokinetics of lithium</td>
</tr>
<tr>
<td>Antipyrine</td>
<td>1 g, single dose</td>
<td>250 mg three times daily</td>
<td>No effect on clearance of antipyrine or urinary recovery of its metabolites</td>
</tr>
</tbody>
</table>